Caplin Point Laboratories Ltd

Caplin Point Laboratories is engaged in the business of pharmaceuticals - producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.(Source : 201903 Annual Report Page No: 109)

Pros:
Company is virtually debt free.
Promoter's stake has increased
Company has good consistent profit growth of 65.81% over 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 44.34%
Cons:
Debtor days have increased from 68.35 to 89.92 days

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
96 103 118 124 131 142 143 146 156 159 187 193
68 71 75 78 82 91 95 93 100 101 123 125
Operating Profit 28 31 43 46 49 51 49 53 56 58 65 67
OPM % 29% 31% 37% 37% 38% 36% 34% 36% 36% 36% 35% 35%
Other Income 2 2 4 4 4 2 3 2 7 8 3 4
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 3 3 5 4 4 5 6 5 6 6 7 7
Profit before tax 27 31 43 46 48 49 45 49 57 60 61 64
Tax % 17% 22% 22% 21% 27% 23% 22% 24% 24% 23% 18% 22%
Net Profit 22 24 33 36 36 38 35 37 44 46 50 50
EPS in Rs 2.97 3.15 4.41 4.81 4.71 4.97 4.76 4.95 6.21 6.06 6.58 6.64
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
81 107 127 173 252 239 402 540 649 695
72 96 105 137 192 175 276 345 417 449
Operating Profit 9 11 22 36 60 64 125 195 232 246
OPM % 11% 10% 18% 21% 24% 27% 31% 36% 36% 35%
Other Income 3 3 2 4 3 4 10 13 19 22
Interest 1 1 1 1 1 0 1 1 1 0
Depreciation 2 1 2 4 8 7 13 19 23 25
Profit before tax 8 11 22 36 53 60 121 188 227 242
Tax % 23% 28% 37% 27% 23% 24% 21% 23% 22%
Net Profit 6 8 14 26 41 46 96 145 177 189
EPS in Rs 0.78 0.99 1.77 3.26 5.23 7.75 12.65 19.15 23.35 25.49
Dividend Payout % 361% 38% 27% 23% 18% 20% 12% 10% 9%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:38.56%
3 Years:39.55%
TTM:23.45%
Compounded Profit Growth
10 Years:%
5 Years:65.81%
3 Years:56.55%
TTM:29.82%
Stock Price CAGR
10 Years:76.34%
5 Years:41.77%
3 Years:11.86%
1 Year:-8.52%
Return on Equity
10 Years:%
5 Years:44.91%
3 Years:44.34%
Last Year:37.72%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
15 15 15 15 15 15 15 15 51
Reserves 14 18 28 47 78 113 210 349 514
Borrowings 10 7 5 3 2 2 1 1 1
33 67 87 115 134 137 133 136 218
Total Liabilities 71 107 135 180 229 267 358 500 747
25 28 33 102 113 144 152 169 227
CWIP 0 13 51 25 31 0 3 15 10
Investments 1 1 1 0 0 0 17 47 70
45 66 50 52 85 122 186 269 441
Total Assets 71 107 135 180 229 267 358 500 747

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
14 28 32 60 50 42 68 66 83
-7 -16 -45 -44 -23 -6 -36 -69 -100
-0 -1 -1 -6 -9 -14 -7 -12 90
Net Cash Flow 7 10 -15 10 19 23 25 -14 73

Ratios Consolidated Figures in Rs. Crores / View Standalone

Jun 2011 Jun 2012 Jun 2013 Jun 2014 Jun 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 31% 52% 64% 68% 62% 69% 64% 49%
Debtor Days 38 25 2 0 8 12 30 85 90
Inventory Turnover 18.05 15.12 17.13 21.47 16.69 19.55 21.27 19.68

Recent Announcements

View all announcements

Annual Reports